Specific analysis of ketone and aldehyde analytes using reagent compounds, labeling strategies, and mass spectrometry workflow
Labeling reagents, sets of labeling reagents, and labeling techniques are provided for the relative quantitation, absolute quantitation, or both, of ketone or aldehyde compounds including, but not limited to, analytes comprising steroids or ketosteroids and includes testosterone. The analytes can be medical or pharmaceutical compounds in biological samples. Methods for labeling, analyzing, and quantifying ketone or aldehyde compounds are also disclosed as are methods that also use mass spectrometry.
1. A method for mass analysis of a ketosteroid in a sample, the ketosteroid comprising an aldehyde or ketone functional group, the method comprising:
derivatizing a ketosteroid comprising an aldehyde or ketone functional group, with a labeling reagent of formula:
Y—(CH 2 )n—ONH 2
to form a labeled ketosteroid,
wherein n is an integer from 2 to 10 and Y is a group selected from the group consisting of:
subjecting the labeled ketosteroid to ionization; and
detecting the ketosteroid by mass analysis.
2. The method of claim 1 , further comprising determining a concentration of the ketosteroid in a sample.
3. The method of claim 1 , further comprising the step of subjecting the labeled ketosteroid to ion fragmentation to yield an ionized reporter group.
4. The method of claim 1 , wherein the step of detecting the ketosteroid is comprised of detecting ions of Y in a mass analyzer.
5. The method of claim 1 , wherein the step of detecting the ketosteroid is comprised of detecting a first transmitted parent ion and a daughter ion fragment by parent-daughter ion transition monitoring.
6. The method of claim 1 , wherein the labeling reagent contains one or more heavy atom isotopes, the method further comprising derivatizing an aldehyde or ketone functional group of a standard compound with a labeling compound that is isobaric to the labeling compound used to form the labeled ketosteroid and measuring the relative concentration of the ketosteroid.
7. The method of claim 1 , wherein the labeling reagent is isotopically enriched with two or more heavy atoms.
8. The method of claim 1 , wherein the ionization produces structurally specific fragment ions and Q3 MRM ions, the labeling reagent is wholly or partly contained in the structurally specific fragment ions, and the method provides both sensitivity and specificity for the Q3 MRM ions.
9. The method of claim 1 , wherein the ketosteroid is selected from DHT, testosterone, epitestosterone, desoxymethyltestosterone (DMT), tetrahydrogestrinone (THG), aldosterone, estrone, 4-hydroxyestrone, 2-methoxyestrone, 2-hydroxyestrone, 16-ketoestradiol, 16 alpha-hydroxyestrone, 2-hydroxyestrone-3-methylether, prednisone, prednisolone, pregnenolone, progesterone, DHEA (dehydroepiandrosterone), 17 OH pregnenolone, 17 OH progesterone, 17 OH progesterone, androsterone, epiandrosterone, and D4A (delta 4 androstenedione).
10. The method of claim 1 wherein n is an integer from 2 to 6.
11. A method for mass analysis of testosterone in a sample comprising:
derivatizing the testosterone in the sample with a labeling reagent of formula:
Y—(CH 2 )n—ONH 2
to form a labeled testosterone,
wherein n is an integer from 2 to 6 and Y is a group selected from the group consisting of:
subjecting the labeled testosterone to ionization; and
detecting the testosterone by mass analysis.
12. The method of claim 11 , further comprising determining a concentration of the testosterone in a sample.
13. The method of claim 11 , further comprising the step of subjecting the labeled testosterone to ion fragmentation to yield an ionized reporter group.
14. The method of claim 11 , wherein the step of detecting the testosterone is comprised of detecting ions of Y in a mass analyzer.
15. The method of claim 11 , wherein the step of detecting the testosterone is comprised of detecting a first transmitted parent ion and a daughter ion fragment by parent-daughter ion transition monitoring.
16. The method of claim 11 , wherein the labeling reagent contains one or more heavy atom isotopes, the method further comprising derivatizing an aldehyde or ketone functional group of a standard compound with a labeling compound that is isobaric to the labeling compound used to form the labeled testosterone and measuring the relative concentration of the testosterone.
17. The method of claim 11 , wherein the labeling reagent is isotopically enriched with two or more heavy atoms.
18. The method of claim 11 , wherein at least two testosterone compounds are derivatized with the labeling reagent and the method further comprises the step of determining a relative concentration between the at least two testosterone compounds.
19. The method of claim 11 , wherein at least two testosterone compounds are derivatized with the labeling reagent and the method further comprises the step of determining an absolute concentration of at least one testosterone.
20. The method of claim 11 , wherein the ionization produces structurally specific fragment ions and Q3 MRM ions, the labeling reagent is wholly or partly contained in the structurally specific fragment ions, and the method provides both sensitivity and specificity for the Q3 MRM ions.